Laura Brege, EVP, Corporate Affairs at ONYX PHARMACEUTICALS INC (ONXX), sold 10,000 shares at $35.01 ($350K) on 2011-04-26, disclosed to the SEC on 2011-04-27.
Scheduled sale ($350k) by EVP, Corporate Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.00 | 8,000 | $280K | 80.0% |
| 2 | $35.01 | 2,000 | $70K | 20.0% |
| Total | $35.00 avg | 10,000 | $350K | 100% |
| Filing → |
| PCRX | BUY | 2024-08-19 | $13K | — | Filing → |
| ACAD | SELL | 2023-06-14 | $112K | — | Filing → |
| PCRX | SELL | 2023-06-07 | $23K | — | Filing → |